Logo image of AVAH

AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Analyst Earnings Estimates

NASDAQ:AVAH - Nasdaq - US05356F1057 - Common Stock - Currency: USD

3.85  +0.04 (+1.05%)

After market: 3.85 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
AVAH revenue by date.AVAH revenue by date.
1.679B
12.27%
1.788B
6.49%
1.895B
6.02%
2.044B
7.85%
2.148B
5.09%
2.258B
5.12%
2.387B
5.71%
EBITDA
YoY % growth
AVAH ebitda by date.AVAH ebitda by date.
115M
16.40%
54.4M
-52.70%
143.772M
164.29%
172.41M
19.92%
185.03M
7.32%
198.59M
7.33%
218.28M
9.91%
EBIT
YoY % growth
AVAH ebit by date.AVAH ebit by date.
94.4M
15.40%
33.1M
-64.94%
113.674M
243.43%
151.42M
33.21%
167.76M
10.79%
180.55M
7.62%
N/A
Operating Margin
AVAH operating margin by date.AVAH operating margin by date.
5.62%1.85%6.00%7.41%7.81%8.00%N/A
EPS
YoY % growth
AVAH eps by date.AVAH eps by date.
0.390.01
-97.44%
-0.12
-1,300.00%
0.01
106.38%
0.08
916.67%
0.15
94.85%
0.28
81.73%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.00
100.00%
0.00
111.32%
0.03
206.00%
0.02
18.98%
0.030.06
1,701.80%
0.07
116.67%
0.05
114.32%
0.07
162.47%
Revenue
Q2Q % growth
509.6M
6.42%
526.86M
7.38%
541.39M
7.21%
543.87M
6.85%
537.9M
5.55%
555.85M
5.50%
571.86M
5.63%
571.71M
5.12%
576.76M
7.22%
EBITDA
Q2Q % growth
42.107M
-2.24%
41.89M
30.86%
49.05M
-8.72%
47.377M
-18.50%
47.168M
12.02%
48.042M
14.69%
52.938M
7.93%
48.042M
1.40%
54.111M
14.72%
EBIT
Q2Q % growth
37.423M
27.75%
37.101M
62.25%
45.608M
22.85%
42.33M
23.87%
42.152M
12.64%
43.35M
16.84%
44.472M
-2.49%
36.72M
-13.25%
43.86M
4.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.02
166.67%
-0.010.03256.86%
Q2 2024
Q2Q % growth
0.01
150.00%
-0.020.03149.02%
Q1 2024
Q2Q % growth
-0.03
40.00%
-0.050.0238.08%
Q4 2023
Q2Q % growth
-0.02
33.33%
-0.020.0017.44%
Q3 2023
Q2Q % growth
-0.03 -0.030.00-10.28%
Q2 2023
Q2Q % growth
-0.02
-166.67%
-0.040.0245.91%
Q1 2023
Q2Q % growth
-0.05
-225.00%
-0.060.0120.20%
Q4 2022
Q2Q % growth
-0.03
-130.00%
-0.02-0.01-77.50%
Q3 2022
Q2Q % growth
-0.03
-127.27%
0.04-0.07-184.03%
Q2 2022
Q2Q % growth
0.03
-70.00%
0.06-0.03-49.67%
Q1 2022
Q2Q % growth
0.04
-50.00%
0.06-0.02-34.75%
Q4 2021
Q2Q % growth
0.10 0.11-0.01-12.07%
Q3 2021
Q2Q % growth
0.11 0.12-0.01-8.84%
Q2 2021
Q2Q % growth
0.10 0.100.00-3.79%
Q1 2021
Q2Q % growth
0.08 0.070.019.43%
AVAH Yearly EPS VS EstimatesAVAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3 0.4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
509.023M
6.49%
505.94M3.083M0.61%
Q2 2024
Q2Q % growth
504.958M
7.00%
503.23M1.728M0.34%
Q1 2024
Q2Q % growth
490.653M
5.20%
493.66M-3.007M-0.61%
Q4 2023
Q2Q % growth
478.841M
6.15%
476.75M2.091M0.44%
Q3 2023
Q2Q % growth
478.01M
7.90%
462.77M15.24M3.29%
Q2 2023
Q2Q % growth
471.945M
6.53%
466.73M5.215M1.12%
Q1 2023
Q2Q % growth
466.413M
3.53%
461.07M5.343M1.16%
Q4 2022
Q2Q % growth
451.1M
8.94%
457.12M-6.02M-1.32%
Q3 2022
Q2Q % growth
443M
7.71%
455.72M-12.72M-2.79%
Q2 2022
Q2Q % growth
443M
1.58%
459.63M-16.63M-3.62%
Q1 2022
Q2Q % growth
450.5M
7.98%
450.18M320K0.07%
Q4 2021
Q2Q % growth
414.1M 431.49M-17.39M-4.03%
Q3 2021
Q2Q % growth
411.3M 454.74M-43.44M-9.55%
Q2 2021
Q2Q % growth
436.1M 442.69M-6.59M-1.49%
Q1 2021
Q2Q % growth
417.2M 422.5M-5.3M-1.25%
AVAH Yearly Revenue VS EstimatesAVAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A -100% 0% N/A
Revenue0% -0.15% 0% -0.05%